Lab Med Online LMO Laboratory Medicine Online 2093-6338 The Korean Society for Laboratory Medicine 10.3343/lmo.2013.3.4.198 Original Article Clinical Chemistry Analytical Performance of Wako and Sekisui Clinical Chemistry Assays on Hitachi LABOSPECT 008 Chae Hyojin M.D. Park Hae-il M.D. Kim Myungshin M.D. Lee Jehoon M.D. Kim Yonggoo M.D. Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea. Corresponding author: Hae-il Park. Department of Laboratory Medicine, Bucheon St. Mary's Hospital, 327-2 Sosa-ro, Wonmi-gu, Bucheon 420-717, Korea. Tel: +82-32-340-2093, Fax: +82-32-340-2219, phi@catholic.ac.kr 10 2013 01 10 2013 3 4 198 212 20 07 2012 25 06 2013 25 06 2013 © 2013, Laboratory Medicine Online 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Background

We evaluated the analytical performance of Wako assays for albumin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN), complement C3 and C4, calcium, creatine kinase (CK), C-reactive protein (CRP), direct bilirubin (DBIL), iron, gamma-glutamyl transferase (GGT), HDL cholesterol (HDLC), inorganic phosphorus (IP), LDL cholesterol (LDLC), total bilirubin (TBIL), total protein (TP), and uric acid (UA), as well as the performance of Sekisui assays for albumin, BUN, calcium, CRP, HDLC, IP, LDLC, TP, and UA by using Hitachi LABOSPECT 008 (Hitachi High-Tech Co., Japan).

 Methods

Liquid Assayed Multiqual Control (Bio-Rad Laboratories, USA) and pooled patients' sera were analyzed for 20 days. Wako linearity material (Wako Pure Chemical Industries, Ltd., Japan) and Sysmex Interference Check A Plus kit (Sysmex Co., Japan) were used to test linearity and interference, respectively. Concentrations of the target analytes were measured using Hitachi LABOSPECT 008 in 100 residual patient specimens and compared to those in Pureauto S series reagent (Sekisui Medical, Japan), which were measured using Hitachi 7600 (Hitachi High-Tech Co., Japan).

 Results

Total coefficients of variation (CVs) for the tested analytes were 0.91-9.26% in Wako and 1.04-7.46% in Sekisui assays. Linearity was demonstrated up to the highest concentration within the analytical range in all the assays except for Wako albumin and Sekisui TP. Wako and Sekisui albumin, BUN, CRP, HDLC, and LDLC assays, and in Wako C3, C4, calcium, and UA assays showed no interference with the test concentrations used. All the tested assays, except for Wako AST, LDLC, and TP, and Sekisui calcium and TP, demonstrated comparability with comparative method for at least one medical decision level.

 Conclusions

Our study results showed that the analytical performances of Wako and Sekisui chemistry assays evaluated using Hitachi LABOSPECT 008 had appropriate analytical performance for clinical use.

 Chemistry Techniques, Analytical Evaluation Studies Clinical Chemistry Tests Hitachi LABOSPECT 008 Hitachi Clinical Chemistry Analytical Instrument LABOSPECT 008 Updated on Sep 2012 http://www.hitachi-hitec.com/science/medical/labospect_008.html Clinical and Laboratory Standards Institute Evaluation of precision performance of quantitative measurement methods approved guideline-second edition Wayne, PA Clinical and Laboratory Standards Institute 2006 Westgard J Desirable biological variation database specifications Updated on Jan 2012 http://www.westgard.com/biodatabase1.htm Clinical and Laboratory Standards Institute Evaluation of the linearity of quantitative measurement procedures: a statistical approach; approved guideline, EP06-A Wayne, PA Clinical and Laboratory Standards Institute 2003 Clinical and Laboratory Standards Institute Method comparison and bias estimation using patient samples; approved guideline-Second edition, EP09-A2 Wayne, PA Clinical and Laboratory Standards Institute 2002 Burtis CA Ashwood ER Tietz textbook of clinical chemistry and molecular diagnostics 5th ed St. Louis Elsevier Saunders 2011 2131 2188 Jacques W Interpretation of diagnostic tests 8th ed Philadelphia Lippincott Williams & Wilkins 2007 8 30 Westgard J Medical decision levels Updated on Jan 2011 http://www.westgard.com/decision.htm Clinical and Laboratory Standards Institute Interference testing in clinical chemistry, EP07-A2 Wayne, PA Clinical and Laboratory Standards Institute 2005 Kang SY Suh JT Kim JH Lee WI Lee HJ Comparison of high sensitivity C-reactive protein assay with a wide assay range Korean J Lab Med 2005 25 227 233 Sisman AR Küme T Tas G Akan P Tuncel P Comparison and evaluation of two C-reactive protein assays based on particle-enhanced immunoturbidimetry J Clin Lab Anal 2007 21 71 76 Zivkovic AM Wiest MM Nguyen UT Davis R Watkins SM German JB Effects of sample handling and storage on quantitative lipid analysis in human serum Metabolomics 2009 5 507 516 Clinical and Laboratory Standards Institute Procedures for the handling and processing of blood specimens for common laboratory tests; approved guideline - Fourth edition, H18-A4 Wayne, PA Clinical and Laboratory Standards Institute 2010 Ji JZ Meng QH Evaluation of the interference of hemoglobin, bilirubin, and lipids on Roche Cobas 6000 assays Clin Chim Acta 2011 412 1550 1553 Steen G Vermeer HJ Naus AJ Goevaerts B Agricola PT Schoenmakers CH Multicenter evaluation of the interference of hemoglobin, bilirubin and lipids on Synchron LX-20 assays Clin Chem Lab Med 2006 44 413 419

Method comparison of Wako or Sekisui assays on Hitachi LABOSPECT 008 and Pureauto S assays on Hitachi 7600.

Interference of common potential interfering substances in Wako and Sekisui assays on Hitachi LABOSPECT 008.

Precision of Wako and Sekisui assays on Hitachi LABOSPECT 008 with control materials and pooled patients' sera

*Minimum specifications for imprecision derived from intra- and inter-individual biologic variations.

Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; C3, complement 3; C4, complement 4; CK, creatine kinase; CRP, C-reactive protein; GGT, gamma glutamyl transpeptidase; HDL, high density lipoprotein; LDL, low density lipoprotein.

Linearity of Sekisui and Wako assays on Hitachi LABOSPECT 008 using linearity materials

Abbreviation: AMR, analytical measurement range.

Method comparison of the Wako and Sekisui assay on Hitachi LABOSPECT 008 against Pureauto S on Hitachi 7600

*Minimum specifications for bias derived from intra- and inter-individual biological variations; †Medical decision levels from "Westgard QC website"[8]; ‡Reference interval from "Interpretation of Diagnostic Tests"[7]; §Reference interval from "Tietz Textbook of Clinical Chemistry and Molecular Diagnostics"[6]; ∥ATP III classification of total, LDL, and HDL cholesterol from "Tietz Textbook of Clinical Chemistry and Molecular Diagnostics"[6].

Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; C3, complement 3; C4, complement 4; CK, creatine kinase; CRP, C-reactive protein; GGT, gamma glutamyl transpeptidase; HDL, high density lipoprotein; LDL, low density lipoprotein.MDL, medical decision level; CI, confidence interval.